Viva Biotech Holdings (HKG:1873)
Hong Kong · Delayed Price · Currency is HKD 2.310
-0.050 (-2.12%)
Feb 13, 2026, 4:08 PM HKT
Viva Biotech Holdings Market Cap
Viva Biotech Holdings has a market cap or net worth of 4.98 billion as of February 13, 2026. Its market cap has increased by 198.47% in one year.
Market Cap
4.98B
Enterprise Value
5.27B
Revenue
2.01B
Ranking
n/a
PE Ratio
34.51
Stock Price
2.31
Market Cap Chart
Since May 9, 2019, Viva Biotech Holdings's market cap has decreased from 6.63B to 4.98B, a decrease of -24.88%. That is a compound annual growth rate of -4.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 4.98B | 31.11% |
| Dec 31, 2025 | 3.80B | 109.02% |
| Dec 31, 2024 | 1.82B | -19.19% |
| Dec 29, 2023 | 2.25B | -32.91% |
| Dec 30, 2022 | 3.35B | -62.94% |
| Dec 31, 2021 | 9.04B | -48.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mirxes Holding Company | 7.08B |
| Ocumension Therapeutics | 5.65B |
| Laekna | 5.30B |
| Shandong Boan Biotechnology | 4.89B |
| Jacobio Pharmaceuticals Group | 4.78B |
| TYK Medicines | 4.78B |
| Qyuns Therapeutics | 4.73B |
| Beijing Luzhu Biotechnology | 4.04B |